companydata.dkGXP PHARMAID ApS: Financial statements 2021
CVR: 29615861
GXP PHARMAID ApS (CVR 29615861) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK 363,324 and a net result of DKK -503,961 compared with DKK 960,283 the year before. That is a decrease of 87% compared with the year before. Equity amounted to DKK 691,287. The solvency ratio was 67.1%. The company had 2 employees in the financial year.
- Gross Profit
- 363,324 kr.
- Profit/Loss
- -503,961 kr.
- Equity
- 691,287 kr.
- Total Assets
- 1,030,858 kr.
- Employees
- 2
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | - | 363 t. | -504 t. | 691 t. | 2 |
| 2020 | - | 2.8 mio. | 960 t. | 1.7 mio. | 3 |
| 2019 | - | 763 t. | -169 t. | 735 t. | 1 |
| 2018 | - | 1.1 mio. | 217 t. | 904 t. | 1 |
| 2017 | - | 1.4 mio. | 142 t. | 687 t. | 1 |
Events in 2021
GXP PHARMAID ApS has published its annual report for 2020. Gross profit came to DKK 2,798,982, and the net result was DKK 960,283.
About GXP PHARMAID ApS
GXP PHARMAID ApS is a Danish company of the type Anpartsselskab based in Brønshøj, founded in 2006. The company is registered under the industry Anden teknisk rådgivning. The management consists of Nusret Asanovski. The company is owned by MAC ANDORBY ApS. The company has 2 employees. In 2024, the company reported a gross profit of DKK 1,340,825 and a net result of DKK 216,532 compared with DKK 513,163 the year before. Equity amounted to DKK 1,096,211.